Loading...
Loading...
Browse all stories on DeepNewz
VisitVertex Pharmaceuticals Sues US Government Over Casgevy Gene Therapy Fertility Support Program
Jul 15, 2024, 06:12 PM
On July 15, Vertex Pharmaceuticals filed a lawsuit against the US government, specifically the US Department of Health and Human Services, seeking a court declaration that a fertility support program for patients prescribed its gene editing therapy, Casgevy, does not violate federal anti-kickback laws. The company is requesting permission to pay for fertility treatment for individuals who receive the Casgevy gene therapy, which can interfere with reproduction.
View original story
Markets
Yes • 50%
No • 50%
Official court records or press releases from Vertex Pharmaceuticals or the US Department of Health and Human Services
Yes • 50%
No • 50%
Official legislative records or announcements from the US Department of Health and Human Services
No • 50%
Yes • 50%
Official court records or press releases from Vertex Pharmaceuticals or the US Department of Health and Human Services
Increase by more than 10% • 25%
Decrease by more than 10% • 25%
Decrease by less than 10% • 25%
Increase by less than 10% • 25%
Stock market data from reputable financial sources such as Bloomberg or Reuters
Case dismissed • 25%
Vertex wins • 25%
US government wins • 25%
Settlement reached • 25%
Official court records or press releases from Vertex Pharmaceuticals or the US Department of Health and Human Services
Mixed • 25%
Indifferent • 25%
Positive • 25%
Negative • 25%
Public opinion polls or surveys conducted by reputable polling organizations